Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced patients with HIV type 1 infection
about
Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?[The Competence Network for HIV/AIDS. Data, Samples, Facts].Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study.Long-term gender-based outcomes for atazanavir/ritonavir (ATV/r)- containing regimens in treatment-experienced patients with HIV.AIDS: The final chapter?
P2860
Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced patients with HIV type 1 infection
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Long-term efficacy and safety ...... ents with HIV type 1 infection
@en
type
label
Long-term efficacy and safety ...... ents with HIV type 1 infection
@en
prefLabel
Long-term efficacy and safety ...... ents with HIV type 1 infection
@en
P2093
P2860
P356
P1476
Long-term efficacy and safety ...... ents with HIV type 1 infection
@en
P2093
Anders Thalme
Jean-Luc Eychenne
Klaus Jansen
Maria Jesus Jimenez-Exposito
Norbert Brockmeyer
Pascal Pugliese
Stephan Dupke
Tina Nakonz
Veronica Svedhem
P2860
P304
P356
10.1089/AID.2012.0092
P577
2012-11-27T00:00:00Z